{"DataElement":{"publicId":"64844","version":"3","preferredName":"Vaccine Therapy Induration Measurement","preferredDefinition":"a numeric value for the longest dimension of swelling or hardening of tissue (e.g., skin) at the site where active immunization of vaccine is administered for therapeutic or preventive purposes.","longName":"VACTX_INDURAT_MSRMT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009354","version":"3","preferredName":"Vaccine Therapy Induration","preferredDefinition":"related to the swelling or hardening of tissue (e.g., skin) at the site where active immunization of vaccine is administered for therapeutic or preventive purposes (stimulating the immune system).","longName":"VACTX_INDURATION","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2486738","version":"1","preferredName":"Vaccine Therapy","preferredDefinition":"Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.","longName":"C15347","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaccine Therapy","conceptCode":"C15347","definition":"Immunotherapy using a preparation that usually contains a complex mixture of disease-related antigens, immunopotentiating agents, and immunomodulators, which stimulate the immune system to destroy pathogenic microorganisms or tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1620EC2C-3B38-4FF3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-13","modifiedBy":"ONEDATA","dateModified":"2006-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2486740","version":"1","preferredName":"Induration","preferredDefinition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","longName":"C25534","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induration","conceptCode":"C25534","definition":"The quality of being hard, the process of hardening, or an abnormally hard spot or place, particularly of the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1620EC2C-3B46-4FF3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-13","modifiedBy":"ONEDATA","dateModified":"2006-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1620A0A3-8AD5-3F28-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015822","version":"3","preferredName":"Vaccine Therapy Induration Measurement","preferredDefinition":"a numeric value for the longest dimension of swelling or hardening of tissue (e.g., skin) at the site where active immunization of vaccine is administered for therapeutic or preventive purposes.","longName":"VACTX_INDURAT_MSRMT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"cm","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"1","format":"99.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184312","version":"1","preferredName":"Measurement","preferredDefinition":"Measurement; the size or magnitude of something.","longName":"C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DB6C8AC6-1DB1-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2006-10-26","changeDescription":"Move to caBIG context as teh preferred Rep class for Measurement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16208165-341C-401F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-13","modifiedBy":"AZIEN","dateModified":"2009-07-10","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811919","version":"1","longName":"Advanced Melanoma","context":"CTEP"},{"publicId":"2811927","version":"1","longName":"Local-Reg Melanoma","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Induration (cm)","type":"Preferred Question Text","description":"Induration (cm)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Induration","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"16208165-33D4-401F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-13","endDate":null,"createdBy":"PWEST","dateCreated":"2006-06-13","modifiedBy":"REEVESD","dateModified":"2011-04-05","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}